© 1997 by Oxford University Press
other |
Serum and Urinary Amino Acid Levels in Sickle Cell Disease
*Departments of Biochemistry, School of Medicine, University of New Mexico Albuquerque NM 87131, U.S.A.
**Departments of Chemical Pathology, Faculty of Medical Sciences, University of Jos Jos, Nigeria
R. H. Glew, Department of Biochemistry, Basic Medical Sciences Building, Room 249, School of Medicine, University of New Mexico, Albuquerque, NM, 87131-5221, U.S.A
Neonates with sickle cell disease (SCD) are of normal size at birth in terms of height and weight. However, by the sixth month of life their growth begins to lag significantly behind that of non-sicklers. We hypothesize that such growth retardation could be explained, at least in part, by the increased excretion of free amino acids in the urine of children with SCD. It is well established that in SCD there are abnormalities in the proximal tubules where amino acids are reabsorbed. We collected serum and urine samples from 13 patients with SCD (age range, 10 months to 14 years), and 17 age and gender-matched controls, and analysed these specimens for free amino acids and creatinine. The SCD population was less well nourished than the controls, as evidenced by the lower serum prealbumin levels in the former group (91.3 v. 127 mg/l, P = 0.01). The serum concentrations of all of the essential amino acids were significantly reduced (21–47 per cent, P < 0.01) in the SCD subjects, as were those of most of the non-essential amino acids (exceptions: alanine, glutamic acid, proline). The urine concentrations of seven of the essential amino acids (indexed to creatinine) were increased in the SCD children. The greatest difference in urinary amino acid excretion was seen with methionine; the SCD subjects excreted 3.6-fold more methionine than the controls. These data indicate that reduced levels of serum amino acids resulting from increased urinary loss of these amlno acids in children with SCD could contribute to the decreased growth rates one sees in children with this genetically inherited hematologic disorder.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. R. Morris, G. J. Kato, M. Poljakovic, X. Wang, W. C. Blackwelder, V. Sachdev, S. L. Hazen, E. P. Vichinsky, S. M. Morris Jr, and M. T. Gladwin Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease JAMA, July 6, 2005; 294(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Steen, T. Emudianughe, M. Hunte, J. Glass, S. Wu, X. Xiong, and W. E. Reddick Brain Volume in Pediatric Patients with Sickle Cell Disease: Evidence of Volumetric Growth Delay? AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|